Stay up to date on New Jersey’s business landscape! Subscribe to our newsletter to receive updates, insights, and highlights directly to your inbox.
Powered by 
Translate
For people that live on “the other” side of the Hudson River, there’s always a bit of “me versus them” in reference to anything going on in the city when contrasted to the efforts within […]
New Jersey Startup Pitch Competitions are Making the Grade Read More »
After a brief stint in second place, Jersey City is once again the most diverse city in the country, according to the annual WalletHub diversity rankings. Jersey City held the distinction as America’s most diverse
Jersey City ranked the most diverse U.S. city in 2020 Read More »
Choose New Jersey will return to Israel to lead a four-day economic mission trip to Tel Aviv and Jerusalem from February 10 to February 13. The delegation will build upon the progress from Governor Murphy’s October
Choose New Jersey’s Delegation to Return to Israel Read More »
With the theme of celebrating innovation and recognizing the dominant role New Jersey plays in drug development, BioNJ celebrated its 2020 Annual Dinner Meeting in East Brunswick on Thursday. “In 2019 there were 54 novel
BioNJ celebrates NJ innovation, growing pharma industry at annual dinner Read More »
Nonprofit Choose New Jersey, which markets the state’s businesses nationwide and abroad, will host a four-day economic mission across Israel next week—though this endeavor will not include Gov. Phil Murphy, as it did in 2018. The
Choose NJ announces February trade mission to Israel Read More »
The sight of film crews on the streets of Newark has become a familiar one. Now, an industry publication is taking notice. For the first time, MovieMaker magazine has named Newark to its list of the
“Cancer can’t wait.” It’s one of the sayings you’ll hear around the Rutgers Cancer Institute of New Jersey’s new Cancer Pavilion — a 12-story, 510,000-square-foot, $750 million building on Somerset Street in New Brunswick situated across
Paladino envisions Rutgers’ Cancer Pavilion as ‘next level’ in treatment Read More »
ALLENDALE, N.J.–(BUSINESS WIRE)– Hitachi Chemical Advanced Therapeutics Solutions, LLC (“HCATS”), a subsidiary of Hitachi Chemical Co., Ltd. representing Hitachi Chemical’s Regenerative Medicine Business Sector (“RMBS”) in North America, today announced the opening of its new
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish